[Federal Register Volume 62, Number 156 (Wednesday, August 13, 1997)]
[Notices]
[Pages 43337-43338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-21421]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the National Advisory Council on Drug Abuse, National Institute on 
Drug Abuse (NIDA) on September 16-17, 1997, at the National Institutes 
of Health, Building 31, 9000 Rockville Pike, Bethesda, MD 20892.
    On September 16, from 9 a.m. to 4 p.m., the meeting will be held in 
Conference Rooms 9 and 10. In accordance with provisions set forth in 
secs. 552b(c)(4), and 552b(c)(6), Title 5, U.S.C. and sec. 10(d) of 
Pub. L. 92-463, this portion of the meeting will be closed to the 
public for the review, discussion, and evaluation of grant 
applications. These applications and the

[[Page 43338]]

discussions could reveal confidential trade secrets or commercial 
property such as patentable material and personal information 
concerning individuals associated with the applications, disclosure of 
which would constitute a clearly unwarranted invasion of personal 
privacy.
    On September 17, from 9 a.m. to 5 p.m., the meeting will be held in 
Conference Room 10. This portion of the meeting will be open to the 
public for announcements and reports of administrative, legislative, 
and program developments in the drug abuse field. Attendance by the 
public will be limited to space available.
    A summary of the meeting and a roster of committee members may be 
obtained from Ms. Camilla L. Holland, NIDA Committee Management 
Officer, National Institutes of Health, Parklawn Building, Room 10-42, 
5600 Fishers Lane, Rockville, Maryland 20857, (301/443-2755).
    Substantive program information may be obtained from Dr. Teresa 
Levitin, Room 10-42, Parklawn Building, 5600 Fishers Lane, Rockville, 
Maryland 20857, (301/443-2755).
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact Dr. Levitin in advance of the meeting.

(Catalog of Federal Domestic Assistance Program Numbers: 93.277, 
Drug Abuse Research Scientist Development and Research Scientist 
Awards; 93.278, Drug Abuse National Research Service Awards for 
Research Training; 93.279, Drug Abuse Research Programs)

    Dated: August 7, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-21421 Filed 8-12-97; 8:45 am]
BILLING CODE 4140-01-M